PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 65 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $438,000 | -78.9% | 62,166 | -64.0% | 0.01% | -76.0% |
| Q3 2019 | $2,074,000 | -20.6% | 172,706 | -20.0% | 0.05% | -10.7% |
| Q2 2019 | $2,613,000 | +46.5% | 215,756 | +52.0% | 0.06% | +43.6% |
| Q1 2019 | $1,784,000 | +88.4% | 141,945 | +0.9% | 0.04% | +56.0% |
| Q4 2018 | $947,000 | -50.3% | 140,714 | -25.0% | 0.02% | -37.5% |
| Q3 2018 | $1,904,000 | +70.5% | 187,653 | +14.7% | 0.04% | +90.5% |
| Q2 2018 | $1,117,000 | -21.5% | 163,667 | -1.2% | 0.02% | -30.0% |
| Q1 2018 | $1,423,000 | +109.3% | 165,606 | +397.3% | 0.03% | +100.0% |
| Q4 2017 | $680,000 | – | 33,302 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |